Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS).

Autor: Livingstone SJ; Diabetes Epidemiology Unit, Division of Population Health Sciences, University of Dundee, The Mackenzie Building, Kirsty Semple Way, Dundee, DD2 4BF, Scotland, UK., Looker HC; Diabetes Epidemiology Unit, Division of Population Health Sciences, University of Dundee, The Mackenzie Building, Kirsty Semple Way, Dundee, DD2 4BF, Scotland, UK., Akbar T; Diabetes Epidemiology Unit, Division of Population Health Sciences, University of Dundee, The Mackenzie Building, Kirsty Semple Way, Dundee, DD2 4BF, Scotland, UK., Betteridge DJ; Department of Endocrinology and Diabetes, University College Hospital, London, UK., Durrington PN; Cardiovascular Research Group, School of Biosciences, University of Manchester, Manchester, UK., Hitman GA; Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK., Neil HA; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK., Fuller JH; Department of Epidemiology and Public Health, University College London, London, UK., Colhoun HM; Diabetes Epidemiology Unit, Division of Population Health Sciences, University of Dundee, The Mackenzie Building, Kirsty Semple Way, Dundee, DD2 4BF, Scotland, UK. h.colhoun@dundee.ac.uk.

Publikováno v: Diabetologia [Diabetologia] 2016 Feb; Vol. 59 (2), pp. 299-306. Date of Electronic Publication: 2015 Nov 17.

Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations.

Autor: Futema M; British Heart Foundation Laboratories, Centre for Cardiovascular Genetics, Institute of Cardiovascular Science, the Rayne Building University College London, London, UK., Plagnol V; Department of Genetics, Environment and Evolution, UCL Genetics Institute, University College London, London, UK., Li K; British Heart Foundation Laboratories, Centre for Cardiovascular Genetics, Institute of Cardiovascular Science, the Rayne Building University College London, London, UK., Whittall RA; British Heart Foundation Laboratories, Centre for Cardiovascular Genetics, Institute of Cardiovascular Science, the Rayne Building University College London, London, UK., Neil HA; Department of Primary Care Health Sciences, NIHR School of Primary Care Research, University of Oxford, Oxford, UK., Seed M; Department of Cardiology, Imperial College Health Services, Charing Cross Hospital, London, UK., Bertolini S; Department of Internal Medicine, University of Genoa, Genoa, Italy., Calandra S; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy., Descamps OS; Centre de Recherche Médicale de Jolimont, Haine St-Paul, Belgium., Graham CA; Queens University Belfast & Regional Genetics Centre, Belfast Health and Social Care Trust/City Hospital Belfast BT9 7AB Northern Ireland UK., Hegele RA; Robarts Research Institute, London, Ontario, Canada., Karpe F; OCDEM, Radcliffe Department of Medicine, University of Oxford, Churchill Hospital, Oxford, UK., Durst R; Cardiology Department, Hadassah Hebrew University Medical Center, Jerusalem, Israel Department of Medicine, Center for Research, Prevention and Treatment of Atherosclerosis, Hadassah Hebrew University Medical Centre, Jerusalem, Israel., Leitersdorf E; Department of Medicine, Center for Research, Prevention and Treatment of Atherosclerosis, Hadassah Hebrew University Medical Centre, Jerusalem, Israel., Lench N; North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children, London, UK., Nair DR; Consultant Lipidologist and Chemical Pathologist Director SAS Laboratory for Cardiac Biomarkers, Royal Free Hospital, London, UK., Soran H; Cardiovascular Trials Unit, University Department of Medicine, Central Manchester University Hospital NHS Foundation Trust, Manchester, UK., Van Bockxmeer FM; Division of Laboratory Medicine, Department of Biochemistry, Royal Perth Hospital, Perth, Australia., Humphries SE; British Heart Foundation Laboratories, Centre for Cardiovascular Genetics, Institute of Cardiovascular Science, the Rayne Building University College London, London, UK.

Publikováno v: Journal of medical genetics [J Med Genet] 2014 Aug; Vol. 51 (8), pp. 537-44. Date of Electronic Publication: 2014 Jul 01.

Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic.

Autor: Futema M; Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Institute of Cardiovascular Science, Rayne Building University College London, London WC1E 6JF, UK., Whittall RA, Kiley A, Steel LK, Cooper JA, Badmus E, Leigh SE, Karpe F, Neil HA, Humphries SE

Publikováno v: Atherosclerosis [Atherosclerosis] 2013 Jul; Vol. 229 (1), pp. 161-8. Date of Electronic Publication: 2013 Apr 18.

Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia.

Autor: Futema M; Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Institute Cardiovascular Science, University College London Medicine School, London WC1E 6JF, UK., Plagnol V, Whittall RA, Neil HA, Humphries SE

Publikováno v: Journal of medical genetics [J Med Genet] 2012 Oct; Vol. 49 (10), pp. 644-9.

Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: a randomised placebo controlled factorial trial.

Autor: Neil HA; NIHR School of Primary Care Research, Division of Public Health & Primary Health Care, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK. andrew.neil@wolfson.ox.ac.uk, Ceglarek U, Thiery J, Paul S, Farmer A, Holman RR

Publikováno v: Atherosclerosis [Atherosclerosis] 2010 Dec; Vol. 213 (2), pp. 512-7. Date of Electronic Publication: 2010 Sep 18.